Skip to main content

Table 2 Physiologic variables during IV JM-1232(-) application (n = 9)

From: The effects of topical and intravenous JM-1232(-) on cerebral pial microvessels of rabbits

 

Pre

Soff10

control

JM10

JM40

JM60

JMoff10

JMoff30

MAP (mmHg)

82 ± 15

92 ± 13

94 ± 91

87 ± 12

83 ± 12*

78 ± 12*

82 ± 11*

90 ± 10

HR (bpm)

279 ± 15

273 ± 15

277 ± 21

260 ± 13

249 ± 27

239 ± 22*

272 ± 17

277 ± 16

RT(°C)

39.6 ± 0.8

39.6 ± 0.8

39.6 ± 0.7

39.6 ± 0.7

39.6 ± 0.7

39.6 ± 0.7

39.5 ± 0.6

39.6 ± 0.6

pH

7.44 ± 0.02

7.42 ± 0.03

7.41 ± 0.03

7.40 ± 0.03

7.40 ± 0.03

7.42 ± 0.03

7.39 ± 0.03

7.39 ± 0.03

PaCO2 (mmHg)

38 ± 3

40 ± 2

40 ± 2

41 ± 4

40 ± 3

40 ± 2

40 ± 2

40 ± 1

PaO2 (mmHg)

441 ± 38

455 ± 25

458 ± 27

456 ± 37

455 ± 33

451 ± 25

453 ± 28

454 ± 27

Na+ (mEq/L)

141 ± 1

141 ± 1

141 ± 1

142 ± 1

141 ± 1

142 ± 1

142 ± 2

142 ± 1

K+ (mEq/L)

3.8 ± 0.2

3.8 ± 0.2

3.8 ± 0.3

3.7 ± 0.2

3.7 ± 0.2

3.6 ± 0.1

3.7 ± 0.1

3.8 ± 0.2

BS(mg/dl)

123 ± 8*

122 ± 7*

128 ± 13

140 ± 12*

144 ± 13*

155 ± 19*

160 ± 19*

158 ± 20*

BE

2.3 ± 3.1

2.1 ± 2.7

2.2 ± 2.4

1.9 ± 2.6

1.9 ± 2.2

0.7 ± 2.6*

0.0 ± 2.8*

0.3 ± 2.1*

Lactate (mmol/L)

2.8 ± 0.7

2.9 ± 0.5

2.8 ± 0.4

3.4 ± 0.6*

4.2 ± 1.0*

5.0 ± 1.5*

5.4 ± 1.5*

5.2 ± 1.2*

  1. Data are expressed as means ± SDs. *P < 0.05 compared with control.
  2. S: sevoflurane, JM: JM-1232(-), Control: just before JM-1232(-) infusion, off 10: 10 min after sevoflurane discontinuation, JM 10, 40, and 60: 10, 40, 60 min after intravenous JM-1232(-) administration, JMoff 10, 30: 10 and 30 min after JM-1232(-) discontinuation, MAP: mean arterial pressure, HR: heart rate, RT: rectal temperature, BS: blood glucose concentration, BE: Base excess.